Literature DB >> 1913997

New hypocholesterolemic abietamide derivatives. II. Synthesis and hypocholesterolemic activity of N-phenyl-delta 8-dihydroabietamides.

Y Fujita1, Y Yoshikuni, T Sotomatsu, T Mori, T Ozaki, K Sempuku, A Ogino, M Kise, H Enomoto.   

Abstract

A series of N-phenyl-delta 8-dihydroabietamide analogs were prepared and tested for hypocholesterolemic activity. The effects of substituents of the phenyl moiety on the activities were quantitatively analyzed by using various substituent parameters. The activities were enhanced by the electron-donating effect of ortho and para substitutents and the bulkiness of ortho substituents. A combination of 2,6-dimethylaniline with resin acids other than delta 8-dihydroabietic acid produced lower activities than N-(2,6-dimethylphenyl)-delta 8-dihydroabietamide, abietane-type carboxamides being somewhat stronger than pimarane-type carboxamides. The conversion of the carboxamide group to other groups resulted in more or less of a decrease in activity, giving evidence that the carboxamide group is important to hypocholesterolemic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913997     DOI: 10.1248/cpb.39.1193

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  (4R,5R,10S)-N-(4-Bromo-phen-yl)dehydro-abietamide.

Authors:  Wen Gu; Shifa Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-28

2.  Dehydroabietic Acid Derivative QC4 Induces Gastric Cancer Cell Death via Oncosis and Apoptosis.

Authors:  Dongjun Luo; Qing Ni; Anlai Ji; Wen Gu; Junhua Wu; Chunping Jiang
Journal:  Biomed Res Int       Date:  2016-02-29       Impact factor: 3.411

3.  The LC-MS/MS-Based Measurement of Isopimaric Acid in Rat Plasma and Application of Pharmacokinetics.

Authors:  Doudou Huang; Jiaxi Cheng; Junqin Mao; Senlin Ma; Zenan Du; Wansheng Chen; Feng Zhang; Lianna Sun
Journal:  Biomed Res Int       Date:  2021-10-15       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.